ARCHIVES

Letter to the Editors: Burzynski Responds To FDA Release Of Annual Report Data

This article is from The Cancer Letter archive.

Vol. 24 No. 20 | May 22, 1998

Download PDF Visit The Full Archive

Related Articles

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

April 16, 1999

A Misdirected Email: CPRIT Official Speaks of “New Regime” As Institute Denies Deepening Crisis

October 19, 2012

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

December 19, 2014

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

June 11, 1993

Three cancer societies to be led by Vanderbilt faculty in 2004

July 18, 2003

New Community Clinical Oncology Programs Aimed At Three Hospital Types; 30 Contracts Possible

November 24, 1978